$19.09
$-0.22 (-1.14%)
End-of-day quote: 05/10/2024
ASX:NEU
Neuren Pharmaceuticals Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$231.94M | $15.42M | $3.20M | $0.72M | $0.50M | $13.99M | $0.63M | $3.15M | $1.67M | $2.93M | $4.79M | |
| GM % | Gross Margin % |
|
88.47% | 17.55% | -197.65% | 0.00% | 0.00% | 56.39% | 0.00% | 0.00% | 0.00% | -241.73% | -80.50% | |
| OM | Operating Margin |
|
85.90% | -4.75% | -257.52% | 0.00% | 0.00% | 41.57% | 0.00% | 0.00% | 0.00% | 0.00% | -138.01% | |
| EPS | Earnings Per Share |
|
$0.00 | $1.20 | $0.00 | $-0.07 | $-0.09 | $-0.11 | $0.07 | $-0.01 | $-0.12 | $-0.16 | $-0.10 | $-0.13 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
0.00% | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Sha. | Shares |
|
127.27m | 125.97m | 125.97m | 114.61m | 100.17m | 100.17m | 97.34m | 92.1m | 88.35m | 81.26m | 75.63m | |
| OCF | Operating Cash Flow |
|
$184.93M | $3.60M | $-9.97M | $-8.08M | $-11.72M | $6.41M | $-5.59M | $-12.38M | $-12.73M | $-6.41M | $-7.11M | |
| FCF | Free Cash Flow |
|
$175.35M | $3.58M | $-9.98M | $-8.08M | $-11.73M | $6.41M | $-5.59M | $-12.39M | $-12.73M | $-6.44M | $-7.78M | |
| FCFS | Free Cash Flow Per Share |
|
$1.45 | $0.03 | $-0.08 | $-0.08 | $-0.12 | $0.06 | $-0.06 | $-0.15 | $-0.15 | $-0.08 | $-0.11 |
